Back
Millicom International Cellular SA Vs. Ultragenyx Pharmaceutical Industry Stock Comparison
Buy
89
TIGO
Millicom International Cellular SA
Last Price:
27.77
Seasonality Move:
0.66%
Sell
35
RARE
Ultragenyx Pharmaceutical
Last Price:
54.41
Seasonality Move:
7.55%
Buy
89
Millicom International Cellular SA (TIGO)
is a Buy
Is Millicom International Cellular SA a Buy, Sell or Hold?
- The current Millicom International Cellular SA [TIGO] share price is $27.76. The Score for TIGO is 89, which is 78% above its historic median score of 50, and infers lower risk than normal.
- TIGO is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Sell
35
Ultragenyx Pharmaceutical (RARE)
is a Sell
Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?
- The current Ultragenyx Pharmaceutical [RARE] share price is $54.43. The Score for RARE is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
- RARE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
TIGO Stock Price Chart
What is Millicom International Cellular SA's stock price today?
-
The Millicom International Cellular SA share price today is $27.76
The current trend is moderately bullish and TIGO is experiencing slight buying pressure.
RARE Stock Price Chart
What is Ultragenyx Pharmaceutical's stock price today?
-
The Ultragenyx Pharmaceutical share price today is $54.43
The current trend is moderately bearish and RARE is experiencing selling pressure, which indicates risk of future bearish movement.
TIGO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.59 | Buy |
| Relative Strength Index (14 RSI): | 59.57 | Buy |
| Chaikin Money Flow: | 6287 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (26.27 - 27.71) | Buy |
| Bollinger Bands (100): | (23.67 - 26.49) | Buy |
RARE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.8 | Buy |
| Relative Strength Index (14 RSI): | 43.18 | Sell |
| Chaikin Money Flow: | -435004 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (55.76 - 58.26) | Sell |
| Bollinger Bands (100): | (40.14 - 54.08) | Buy |
TIGO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 27.87 | Sell |
| 20-day SMA: | 27.11 | Buy |
| 50-day SMA: | 26.08 | Buy |
| 200-day SMA: | 21.74 | Buy |
| 8-day EMA: | 27.82 | Sell |
| 20-day EMA: | 27.26 | Buy |
| 50-day EMA: | 26.26 | Buy |
| 200-day EMA: | 22.66 | Buy |
RARE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 57.08 | Sell |
| 20-day SMA: | 56.96 | Sell |
| 50-day SMA: | 52.99 | Buy |
| 200-day SMA: | 46.88 | Buy |
| 8-day EMA: | 56.5 | Sell |
| 20-day EMA: | 56.46 | Sell |
| 50-day EMA: | 53.4 | Buy |
| 200-day EMA: | 47.32 | Buy |
Millicom International Cellular SA Earnings Growth & TIGO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.35 per share, an increase next quarter of $0.53 per share, an increase this year of $1.71 per share, and an increase next year of $0.96 per share.
Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.53 per share, an increase next quarter of $0.18 per share, an increase this year of $1.07 per share, and an increase next year of $1.02 per share.
Millicom International Cellular SA Technical Analysis
| Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Ultragenyx Pharmaceutical Technical Analysis
| Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||